Erkes, Annett
Mücke, Stefanie
Reschke, Maik
Boch, Jens
Grau, Jan
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BO 1496/8-1, GR 4587/1-1)
European Cooperation in Science and Technology (CA16107)
Martin-Luther-Universität Halle-Wittenberg
Article History
Received: 17 June 2021
Accepted: 25 November 2021
First Online: 29 December 2021
Declarations
:
: Not applicable.
: Not applicable.
: JB is a part owner of patents governing the use of transcription activator-like effectors (TALEs). AE, SM, MR and JG declare that they have no competing interests.